Table 1 Base-Line Characteristics of the Patients
From: Prehospital lung ultrasound for the diagnosis of cardiogenic pulmonary oedema: a pilot study
Characteristic | (n = 40) |
|---|---|
Age - years | |
- Median (IQRa) | 74 (67–81) |
- Range | 56–95 |
Sex – no. (%) | |
- Male | 14 (35.0) |
Smoking status – no. (%) | |
- Never smoked | 5 (12.5) |
- Current smoker | 9 (23.5) |
- Previous smoker | 22 (55.0) |
- Unknown status | 4 (10.0) |
Medical history – no. (%) | |
- COPD | 21 (52.5) |
- Asthma | 1 (2.5) |
- Interstitial lung disease | 3 (7.5) |
- Coronary artery disease | 13 (32.5) |
- Heart failure | 4 (10.0) |
- Valvular heart disease | 4 (10.0) |
- Arterial hypertension | 19 (47.5) |
- Thromboembolic disease | 4 (10.0) |
- Diabetes mellitus | 8 (20.0) |
- Stroke | 5 (12.5) |
- Current or previous malignancy | 10 (25.0) |
Medication at admission – no. (%) | |
- Inhaled bronchodilators | 20 (50.0) |
- Inhaled corticosteroids | 16 (40.0) |
- Oral corticosteroids | 7 (17.5) |
- Aspirin | 11 (27.5) |
- Clopidogrel | 3 (7.5) |
- Persantin | 3 (7.5) |
- Anticoagulants | 10 (25.0) |
- Beta-blockers | 8 (20.0) |
- ACE inhibitorsb | 12 (30.0) |
- Calcium-channel blockers | 12 (30.0) |
- Diuretics | 22 (55.0) |
- Digoxin | 5 (12.5) |
- Amiodarone | 2 (5.0) |